摘要
阿尔茨海默氏病(AD)是一种遗传(70%)和环境(30%)导致的多因素疾病。在遗传因素中是与家族史的疾病(家族性阿尔茨海默氏病,FAD)和散发性阿尔茨海默氏病(SAD)的基因有关。基因:APP(淀粉样前体蛋白),PSEN1(早老素1)和PSEN2(早老素2)负责家族性阿尔茨海默氏病的存在。APOE基因是负责疾病的散发形式。对免疫原因有关的其他分子因素(TREM2)的疾病是一种脂质紊乱(ABCA1,ABCA7)或生物巯基(MTHFD1)代谢和代谢产物的运输(BIN1)。目前,APOE被认为对家族性阿尔茨海默氏病和散发性阿尔茨海默氏病是一个危险因素。 阿尔茨海默氏病的病理机制是最常见的解释为基于淀粉样蛋白级联理论。这一理论与家族性阿尔茨海默氏病相关,虽然有报告显示其发生的概率在散发性阿尔茨海默氏病。看来,过度沉积β-淀粉样蛋白(Aβ)肽和细胞内神经原纤维缠结tau蛋白过度磷酸化的形式有助于脱氧核糖核酸和核糖核酸的损伤。此外,它被认为,核糖核酸干扰可以影响的病理蛋白(β-淀粉样蛋白,tau蛋白)的水平,以及阿尔茨海默氏病发病和进展。 家族性阿尔茨海默氏病和散发性阿尔茨海默氏病的发病机制完整的了解可能有助于寻找早期的临床诊断和了解后发生的疾病,这可能有助于调整程序,并影响更有效的治疗这种不可治愈的神经系统疾病。
关键词: 遗传和生化因素,脱氧核糖核酸,核糖核酸,家族性阿尔茨海默氏病,散发性阿尔茨海默氏病。
Current Alzheimer Research
Title:Molecular Basis of Familial and Sporadic Alzheimer's Disease
Volume: 13 Issue: 9
Author(s): Jolanta Dorszewska, Michal Prendecki, Anna Oczkowska, Mateusz Dezor, Wojciech Kozubski
Affiliation:
关键词: 遗传和生化因素,脱氧核糖核酸,核糖核酸,家族性阿尔茨海默氏病,散发性阿尔茨海默氏病。
摘要: Alzheimer’s disease (AD) is a multifactorial disease with genetic (70%) and environmental (30%) causes. Among the genetic factors are genes associated with a family history of the disease (familial AD, FAD) and sporadic AD (SAD). The genes: APP (amyloid precursor protein), PSEN1 (Presenilin 1) and PSEN2 (Presenilin 2) are responsible for the presence of FAD. The APOE gene is responsible for the sporadic form of the disease. Other molecular factors related to the immunological cause (TREM2) of the disease are a disorder of the lipid (ABCA1, ABCA7) or biothiol (MTHFD1) metabolism and of the transport of metabolites (BIN1). Currently, it is believed that APOE is a risk factor for both SAD and late-onset FAD.
The pathomechanism of AD is most commonly explained as based on the amyloid cascade theory. This theory is related to the FAD, although there are reports indicating the probability of its occurrence in the SAD. It seems that the excessive deposition of β-amyloid (Aβ) peptides and intracellular neurofibrillary tangles of tau protein hyperphosphorylated forms contribute to the damage of both DNA and RNA. Furthermore, it is believed that RNA-interference can affect both the level of pathological proteins (Aβ, tau protein) and the onset and progress of AD.
It seems that a complete understanding of both FAD and SAD pathogenesis may contribute to the search for earlier clinical diagnosis and to an understanding of later occurrence of the disease, which may help modify its course and affect more effective therapy of this incurable neurological disease.
Export Options
About this article
Cite this article as:
Jolanta Dorszewska, Michal Prendecki, Anna Oczkowska, Mateusz Dezor, Wojciech Kozubski , Molecular Basis of Familial and Sporadic Alzheimer's Disease, Current Alzheimer Research 2016; 13 (9) . https://dx.doi.org/10.2174/1567205013666160314150501
DOI https://dx.doi.org/10.2174/1567205013666160314150501 |
Print ISSN 1567-2050 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5828 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Ascorbic Acid: Its Role in Immune System and Chronic Inflammation Diseases
Mini-Reviews in Medicinal Chemistry Patent Selections:
Recent Patents on Biomarkers Appropriate Utilization of Restricted Antibiotics in a General Hospital of a Perfecture Area in Greece
Current Drug Safety Preface [ Focus on NeuroAIDS ]
Current HIV Research Surgical Complications of Hyperglycaemia
Current Diabetes Reviews Relevance of the Neuropeptide Y System in the Biology of Cancer Progression
Current Topics in Medicinal Chemistry In Vivo Imaging of the Metabotropic Glutamate Receptor 1 (mGluR1) with Positron Emission Tomography: Recent Advance and Perspective
Current Medicinal Chemistry Cellular and Molecular Effects of Macrolides on Leukocyte Function
Current Pharmaceutical Design Cell and Gene-Based Therapies for the Lysosomal Storage Diseases
Current Gene Therapy Nutraceuticals, Nutritional Therapy, Phytonutrients, and Phytotherapy for Improvement of Human Health: A Perspective on Plant Biotechnology Application
Recent Patents on Biotechnology Targeting Kinase-activating Genetic Lesions to Improve Therapy of Pediatric Acute Lymphoblastic Leukemia
Current Medicinal Chemistry Advances in Whole Genome Sequencing Technology
Current Pharmaceutical Biotechnology The Chemistry of Mycophenolic Acid - Synthesis and Modifications Towards Desired Biological Activity
Current Medicinal Chemistry NADPH and Iron May Have an Important Role in Attenuated Mucosal Defense in Helicobacter pylori Infection?
Mini-Reviews in Medicinal Chemistry PI3K/Akt/mTOR Pathway Inhibitors in Cancer: A Perspective on Clinical Progress
Current Medicinal Chemistry Targeted Enzyme Prodrug Therapies
Mini-Reviews in Medicinal Chemistry When Does Food Refusal Require Professional Intervention?
Current Nutrition & Food Science Investigating Mitochondrial Dysfunction to Increase Drug Safety in the Pharmaceutical Industry
Current Drug Targets Molecular Mechanisms of Ischemic Neuronal Cell Death - With Relevance to Alzheimers Disease
Current Alzheimer Research High-Throughput Screening Technologies for Botulinum Neurotoxins
Current Topics in Medicinal Chemistry